as on December 3, 2025 at 4:01 pm IST
Day's High
0.83%
Upside
52 Week's Low
52 Week's High
59.48%
Downside
29.27%
Upside
as on December 3, 2025 at 4:01 pm IST
Market Cap
₹230.92 Cr
Return on Equity (ROE)
2.96
PE Ratio (TTM)
0Return on capital employed (ROCE)
6.38
Beta (LTM)
0.84
P/B Ratio
0.72
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-36.25
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Aarey Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 230.92 | 17.57% | 0.00 | 4 | 473 | |
| NA | 2,000.20 | 5.16% | 0.00 | 100 | 390 | |
| BUY | 9,885.79 | 7.57% | 0.00 | 135 | 498 | |
| NA | 293.39 | 8.2% | 0.54 | -10 | 82 | |
| NA | 50.66 | 0.12% | 0.00 | -5 | 10 |
Search interest for Aarey Drugs & Pharmaceuticals Ltd Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aarey Drugs & Pharmaceuticals Ltd.
Aarey Drugs & Pharmaceuticals Ltd’s net profit fell -36.25% since last year same period to ₹1.02Cr in the Q2 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -25.55% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 30 Nov 2018 - translating a dividend yield of 0.12%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 53.23% to 54.07% in Sep 2025 quarter
Best in 1 Year
![]()
In the last 1 year, AAREYDRUGS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.1% return, outperforming this stock by 22.9%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 44.80% of holdings in Sep 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 1.97% to 1.13% in Sep 2025 quarter
Price Dip
![]()
In the last 7 days, AAREYDRUGS stock has moved down by -8.2%
| Organisation | Aarey Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Mihir R Ghatalia |
| E-voting on shares | Click here to vote |
Aarey Drugs & Pharmaceuticals Ltd share price today stands at ₹77.36 as on at the close of the market. Aarey Drugs & Pharmaceuticals Ltd share today touched a day high of ₹78 and a low of ₹77.36.
Aarey Drugs & Pharmaceuticals Ltd touched a 52 week high of ₹100 and a 52 week low of ₹31.35. Aarey Drugs & Pharmaceuticals Ltd share price today i.e. is closed at ₹77.36, which is -22.64% down from its 52 week high and 146.76% up from its 52 week low.
Aarey Drugs & Pharmaceuticals Ltd market capitalisation is ₹230.92 Cr as on .
To buy Aarey Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
Aarey Drugs & Pharmaceuticals Ltd trading volume is 44.86K as on . This means that 44.86K shares of Aarey Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.